Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Zimmer Biomet Holdings (ZBH)
TipRanks13:30 ET
Taysha Gene Therapies Analyst Ratings
Benzinga13:18 ET
Taysha Gene Therapies Analyst Ratings
BenzingaApr 30 10:26 ET
Taysha Gene Therapies Analyst Ratings
BenzingaApr 19 10:41 ET
Taysha Gene Therapies Analyst Ratings
BenzingaApr 18 09:35 ET
Taysha Gene Therapies Analyst Ratings
BenzingaApr 9 06:45 ET
Taysha Gene Therapies (TSHA) Gets a Buy From Truist Financial
TipRanksMar 28 08:16 ET
Taysha Gene Therapies Analyst Ratings
BenzingaMar 21 11:36 ET
Positive Clinical Trials Bolster Buy Rating for Taysha Gene Therapies
TipRanksMar 21 07:35 ET
Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Viridian Therapeutics (VRDN)
TipRanksMar 21 06:40 ET
Taysha Gene Therapies Analyst Ratings
BenzingaMar 21 04:48 ET
Buy Rating on Taysha Gene Therapies Anchored by Promising TSHA-102 Clinical Data and Upcoming Pediatric Study Catalysts
TipRanksMar 21 02:38 ET
Buy Rating Affirmed for Taysha Gene Therapies Amid Positive Clinical Progress and Robust Financial Health
TipRanksMar 20 22:25 ET
Taysha Gene Therapies Analyst Ratings
BenzingaMar 20 07:02 ET
Buy Rating Reaffirmed for Taysha Gene Therapies Amid Clinical Progress and Financial Stability
TipRanksMar 20 06:55 ET
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Taysha Gene Therapies (TSHA)
TipRanksMar 20 00:40 ET
Buy Rating Affirmed for Taysha Gene Therapies Amid Positive Rett Syndrome Program Developments
TipRanksMar 1 04:59 ET
Taysha Gene Therapies Analyst Ratings
BenzingaFeb 29 15:00 ET
Buy Rating Affirmed for Taysha Gene Therapies Amid Positive REVEAL Study Advancements and Strategic Intrathecal Administration Approach
TipRanksFeb 29 09:45 ET
Buy Rating Affirmed for Taysha Gene Therapies Amid Promising TSHA-102 Trials and Market Potential
TipRanksFeb 21 08:13 ET
No Data
No Data